KOBAYASHI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.48 USD | -16.56% |
|
-.--% | -26.22% |
| May. 24 | Japan companies hog the spotlight as hedge funds tout their top Asia picks | RE |
| Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Evolution of the average Target Price on Kobayashi Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
8027c16b82.CZh5GcJ25i_Il1a82pLzW7sZdWeG4a3tMFKmIxS3J-4.SsIIKKhDlR-e4yLNkqfDbfxTMxf0pcucCBzySlfcUqdM0zRBixWBVaffMQ~b49cc0d01318a06eec9f78d6433a79c6
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
5,517
JPY
Average target price
6,348
JPY
Spread / Average Target
+15.07%
High Price Target
7,000
JPY
Spread / Highest target
+26.88%
Low Price Target
5,800
JPY
Spread / Lowest Target
+5.13%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kobayashi Pharmaceutical Co., Ltd.
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4967 Stock
- KBYPF Stock
- Consensus Kobayashi Pharmaceutical Co., Ltd.
